Next week, NIH Director Francis S. Collins is going to testify before the Senate health appropriations panel about the president’s 2018 budget request for medical research.
That budget request—in case you haven’t read the approximately 8,523,283 stories I’ve written on this (thanks a lot, people)—would cut the NIH’s budget by nearly a quarter of its current level, from $34 billion to $25.9 billion. Basically, the NIH would see its lowest funding level since the 1980s.
Collins has told both House and Senate appropriators for years that what the agency really needs are steady, predictable funding increases both to keep new innovations coming and to prevent the next generation of researchers from dropping out of science.
But Dr. Collins also just learned about two weeks before the hearing that the president decided to keep him on permanently, and his job as a presidential appointee is to present the budget in front of him.
I’m sure this won’t be awkward at all…
Both parties in Congress love the NIH and respect Dr. Collins. Both Sen. Roy Blunt (R-Mo.), who heads this Senate health appropriations panel, and his House counterpart Rep. Tom Cole have indicated such steep cuts for the NIH are unlikely to happen.
Congress also just gave NIH two consecutive $2 billion annual increases, plus another $4.8 billion from 21st Century Cures. So a lot of folks, like Bloomberg Intelligence analyst Brian Rye, think lawmakers are unlikely to turn around and yank out $8 billion from the agency.
Stay tuned, Thursday, June 22 at 10 am.
Follow me at @MedResJourno for exciting live tweets…err, at least hopefully mildly entertaining ones.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)